Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 52 of 58, showing 10 Applications out of 576 total, starting on record 511, ending on 520

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

511.

ECCT/24/12/03   PrEMIA Implementation study
    Multi-product PrEP delivery to young women seeking reproductive health services and coverage of HIV prevention   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD( (THIKA) PROJECT
 
04-05-2025 View

512.

ECCT/16/07/05   HESTIA 1
    Multicentre, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric patients with sickle cell disease   
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Kemri CRDR research center at Chandaria Health Centre Dagoretti (Nairobi City county)
3. Clinical Research Annex at the Siaya County Referral Hospital (Siaya county)
4. Kondele Children’s Hospital, KEMRI – Centre for Clinical Research (Kisumu county)
 
19-09-2016 View

513.

ECCT/16/09/02   Monitoring Pre-Exposure Prophylaxis for Young Adult Women ( (MPYA)
    Next generation real-time monitoring for PrEP adherence in young adult women.   
Principal Investigator(s)
1. Prof. Elizabeth Anne Bukusi Bukusi
2. Dr. Stella Njuguna Njuguna
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
 
27-09-2016 View

514.

ECCT/20/05/03   A5381
    Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or with Rifampicin-Containing TB Treatment   
Principal Investigator(s)
1. Victor Mudhune
Site(s) in Kenya
Kisumu Clinical Research Center
 
21-08-2020 View

515.

ECCT/26/02/08   SOAR Study
    Optimizing Smoking Cessation and Unhealthy Alcohol Use Treatment Among People Living with Human Immunodeficiency Virus (PLWH) In Nairobi, Kenya   Abbreviated as SOAR Study   Smoking cessation Optimization and unhealthy Alcohol use Research, SOAR, Study.       
Principal Investigator(s)
1. DR. EMILY KOECH
Site(s) in Kenya
Riruta Hospital
 
19-06-2026 View

516.

ECCT/19/10/03   Smoking Cessation Study for PLHIV
    Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya   
Principal Investigator(s)
1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch
Site(s) in Kenya
Mathari National Teaching and Referral Hospital
 
03-04-2020 View

517.

ECCT/21/03/02   PB-SAM
    Pancreatic Enzymes and Bile Acids: A Non-Antibiotic approach to Treat Intestinal Dysbiosis in Acutely Ill Severely Malnourished Children.   
Principal Investigator(s)
1. Robert Bandsma
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
4. Migori County Hospital (Migori county)
 
08-06-2021 View

518.

ECCT/08/20/01   Partners PrEP Study
    Parallel comparison of Tenofovir and Emtricitabine/Tenofovir pre exposure prophylaxis to prevent HIV-1 acquisition within HIV-1 discordant couples   
Principal Investigator(s)
1. James Njogu Kiarie
2. CAREY FARQUHAR,
3. Grace John Stewart
Site(s) in Kenya
1. Nairobi (Nairobi City county)
2. Thika (Kiambu county)
3. Eldoret (Uasin Gishu county)
4. Kisumu (Kisumu county)
 
09-10-2013 View

519.

ECCT/08/08/03   Partners PrEP Study
    Parallel Comparison of Tenofovir and Emtricitabine/Tenofovir Pre-exposure Prophylaxis to Prevent HIV-1 Acquisition  within HIV-1 Discordant Couples.    
Principal Investigator(s)
1. Prof. Connie Celum
Site(s) in Kenya
1. Kenya- Eldoret (Uasin Gishu county)
2. Kenya – Nairobi (Nairobi City county)
3. Kenya – Kisumu (Kisumu county)
4. Kenya – Thika (Uasin Gishu county)
 
12-11-2008 View

520.

ECCT/08/06/01   PARTNERS PrEP
    Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
1. Kisumu site (Kisumu county)
 
30-07-2008 View